Dr. Alexander Kenneth Doo graduated from Glasgow University and did his post graduate training in Obstetrics and Gynaecology in London where he completed his specialist training. He then did a Clinical Fellowship in Infertility and also in Fetal Medicine, and has been published in peer reviewed journal.
He is the Director of The Women’s Clinic and The IVF Clinic, the Honorary Consultant at the Matilda International Hospital, President of the Hong Kong Society of Reproductive Medicine and Vice President of the Asian Society for Fertility Preservation.
Academician, Chinese Academy of Sciences
Chair and Professor, Department of Obstetrics & Gynecology
Director, Center for Reproductive Medicine
Jinan, P. R. China.
Director, National Research Center for ART and Reproductive Genetics, China.
Director, The Key laboratory for ART and Reproductive Genetics,
Ren Ji Hospital, School of Medicine,
Shanghai Jiao Tong University
Prof. Chen focuses on reproductive endocrinology, reproductive genetics and assisted reproductive technology: PCOS, POF/POI, RSA, IVF/ICSI, PGD/PGS, etc. She has more than 200 publications on journals such as NEJM, Lancet, Nature, Cell, Nat Genet, JCI, PNAS, Cell Reasearch, Am J Hum Genet, Nat Commun, Hum Reprod Update, Fertil Steril, Hum Reprod, etc.
Prof. Chen serves as Secretary General of International Federation of Fertility Societies (IFFS), Executive Member of Asia Pacific Initiative on Reproduction(ASPIRE, 2014-2016), Board Member of Preimplantation Genetic Diagnosis International Society (PGDIS), Board Member of PGDSIG at ASRM, Director of Chinese Gynecological Endocrinology of OB/GYN Society.
Contributions to the Journals including Associate Editor: Human Reproduction Update(2016-2019); International Consultant: American Journal of Obstetrics and Gynecology; Editorial Board Member: Asia Journal of Andrology; Deputy Editor-in-Chief: Chinese Journal of Obstetrics and Gynecology(Chinese), etc.
Professor Ri-Cheng Chian is Director at Center for Reproductive Medicine, Shanghai 10th People’s Hospital of Tongji University, P. R. of China. Before joining the current position, Dr. Chian was an Associate Professor with Tenure at Department of Obstetrics and Gynecology, Faculty of Medicine, McGill University, Montreal, Canada. Dr. Chian is the key person in the development of in vitro maturation (IVM) of human oocytes for clinical application and for cryopreservation of human oocytes which resulted in pregnancies and live births at McGill University Health Center (MUHC) in Canada. He has patents and products licensed with several companies as well.
Dr. Chian published more than 200 research papers in journals and gave presentations at many international/regional conferences. Dr. Chian edited three books and contributed to various book chapters. As an invited guest speaker, Dr. Chian delivered lectures in many different societies and countries. Dr. Chian was a former Associate Editor for the journal, Human Reproduction, Journal of Assisted Reproduction & Genetics, and an Editorial Board Member for two other journals. Dr. Chian is acting as a reviewer for many other scientific journals including Fertility and Sterility, Human Reproduction, Biology of Reproduction, Reproductive BioMedicine Online, Endocrinology, The Journal of Clinical Endocrinology & Metabolism, The Lancet and BMJ, etc.
Dr. Chian speaks English, Chinese, Korean, Japanese and has some knowledge of French.
Dr. Amparo Mifsud Giner received her Master´s degree in Biological Sciences (Speciality in Biochemistry and Molecular Biology) from the University of Valencia, Spain. She received her PhD degree in Molecular Biology at the University of Singapore (Department of Obstetrics and Gynaecology) were she studied the polymorphisms of the CAG repeats located in the exon 1 of the androgen receptor (AR) gene.
From 2001 she works as embryologist at IVI, first at IVI –MADRID and then at IVI-VALENCIA, one of the biggest infertility clinics in Spain. She plays an important role in the of oocyte and embryo vitrification program, in the implementation of the various time-lapse systems and as a member of the PGS team in the IVF laboratory. She is a teacher of the Master of Biotechnology at Valencia. As senior embryologist she has given many courses and seminars regarding the various procedures of the IVF laboratory as well as presented their clinical results and experience in various national and internationals congresses.
Dr. Norbert Gleicher graduated from Tel Aviv University Sackler School of Medicine in Israel. After completion of his residency training and fellowship in reproductive immunology at Mount Sinai Medical Center in New York City, he held various medical and administrative positions at some of the best hospitals and universities in the US. In 1981, Dr. Gleicher founded the Center for Human Reproduction (CHR), where he is currently Medical Director and Chief Scientist. He also holds an appointment as Guest Investigator at Rockefeller University and Professor (Adj.) at Medical University Vienna.
Dr. Gleicher has published hundreds of peer-reviewed scientific papers, abstracts and book chapters, as well as edited textbooks and served as editor for many specialty journals. His editorial roles have included founding Editor-in-Chief for the American Journal of Reproductive Immunology (AJRI) and the Journal of In Vitro Fertilization and Embryo Transfer (renamed Journal of Assisted Reproduction and Genetics in 1992). Currently, he serves as Academic Editor for PLoS ONE, and is a member of multiple editorial boards.
In 2009, he was invited to give the prestigious Patrick Steptoe Memorial Lecture to the British Fertility Society, in recognition of his lifelong contribution to the advancements in reproductive endocrinology and infertility. A popular speaker at worldwide conferences, Dr. Gleicher travels extensively while maintaining his role in clinical patient care and research at CHR. He has been repeatedly one of a handful of reproductive endocrinologists in New York City listed by the New York Times Magazine on its “Super Doctors” list, as chosen by peers.
Dr. Sonia Herraiz is a full-time scientist at IVI Foundation leading the Ovarian rejuvenation and Fertility Preservation research group, visiting scholar at Yale School of Medicine, and part of the Fertility Preservation Unit at La Fe University Hospital in Valencia.
Her scientific career is focused in the achievement of ovarian rejuvenation by several approaches like the autologous stem cell transplantation or the ovarian fragmentation. She has authored over 30 peer-reviewed scientific papers and book chapters in international journals. She has been prized by the Spanish Fertility Society in 2016 and by the Society of Reproductive Investigation in 2018 and 2020. Furthermore, is Professor in the Master’s Degree in Biotechnology of Assisted Human Reproduction (University of Valencia, UV) since 2016.
Dr. Kazuhiro Kawamura is Director of Advanced Reproductive Medicine Research Center of International University Health and Welfare School of Medicine. He is also professor of Obstetrics and Gynecology of International University of Health and Welfare School of Medicine. He received his medical and philosophy degrees from the Akita University School of Medicine. His OB/GYN and Reproductive Endocrinology and Infertility training was at the Akita University School of Medicine. He was also a Postdoctoral Fellow at Stanford University School of Medicine with Dr. Aaron JW Hsueh. In addition to teaching and clinical practice, he has published over 150 original articles in ovarian physiology and Reproductive Endocrinology and Infertility. He collaborated with Dr. Hsueh to establish an in vitro activation (IVA) method to treat infertility in patients with primary ovarian insufficiency (premature ovarian failure) and achieved successful pregnancies/deliveries. Now, he is expanding the IVA treatment and studying to improve the clinical outcome of IVA using different approaches.
Monica M. Laronda PhD is the Director of Foundational and Translational Research for the Fertility & Hormone Preservation & Restoration Program at the Ann & Robert H. Lurie Children’s Hospital of Chicago. She is the Warren & Eloise Batts Scholar at the Stanley Manne Children’s Research Institute and Assistant Professor in the Department of Pediatrics at the Feinberg School of Medicine at Northwestern University.
Professor William Ledger is Head of Discipline of Obstetrics and Gynaecology of the Faculty of Medicine at the University of New South Wales, Director of Reproductive Medicine and Senior Staff Specialist at the Royal Hospital for Women and Chair of the Research and Development Committee and a fertility specialist at IVFAustralia.
Professor Ledger is a member of the RANZCOG Research Committee and the Scientific Advisory Committee of the Fertility Society of Australia. Recently, he was a member of the NHMRC Working Party to review national guidelines on ethics and ART. He is a member of the Editorial Board of 9 scientific journals, author of 276 journal articles and 17 books, and President of the13th biennial congress of the Pacific Society for Reproductive Medicine (PSRM 2022)
His research interests focus on in vitro fertilisation and assisted reproduction, impacts of reproductive ageing and disorders such as endometriosis, premature ovarian failure and polycystic ovary syndrome on fertility and quality of life, reproductive effects of cancer treatment and onco-fertility and health economic and demographic aspects of infertility.
Dr. Liu obtained his Ph.D. from Umeå University, Sweden in September 1999. After his postdoctoral period at Harvard Medical School, USA, he became an assistant professor in 2003 in Umeå University. He became a professor in 2010 in Umea University and Gothenburg University, Sweden, and moved to the University of Hong Kong in 2018. Ever since he established his own research group, he has been studying mechanisms of female germ cell development, especially for the topic of activation of primordial follicles. In the past few years, his group has published papers in top journals such as PNAS, Current Biology, Journal of Cell Biology, Cell Research and Nature Medicine. The studies published not only represent advances in basic research but also has the implication for translating into possible novel treatment of female infertility.
Yoshiharu Morimoto MD. PhD. is an internationally recognized clinician, researcher, and educator in the field of reproductive biology and medicine.
He is the CEO of IVF Japan Group consisted of HORAC Grand Front Osaka Clinic (President/founder), IVF Osaka Clinic(founder), and IVF Namba Clinic(founder).
He is widely known as a pioneer of reproductive medicine. He started to offer and spread a new idea of integrated medical method to the world. Also, his cutting-edge technology “AUGMENT” has been introduced for intractable patients. These active scientific works have enabled him to treat more than 2 million patients so far with a high pregnancy success rate.
He also serves many roles such as; the president of International Society for In Vitro Fertilization (ISIVF), the Associate Editor of the Journal of “Reproductive Sciences” (Society for Reproductive Investigation), the Editorial Board member of the Journal of “Fertility and Reproduction” (the official journal of Asia Pacific Initiative on Reproduction), the Journal of “Fertility and Sterility” (the official journal of the American Society for Reproductive Medicine), and the Journal of “Reproductive Medicine and Biology” (the official journal of Japan Society for Reproductive Medicine.)
Professor Schatten is Professor of Obstetrics, Gynecology and Reproductive Sciences, Cell Biology, Bioengineering and Division Director of the Division of Developmental and Regenerative Medicine. Dr. Schatten has directly trained >50 doctoral and postdoctoral fellows, along with several MD, MD-PhD and DVM trainees. He is active in advanced research training and was the founding director of the FRONTIERS IN REPRODUCTION, the premier reproduction training vehicle for MD and PhDs. He is currently President of UNESCO’s International Cell Research Organization. With extensive funding from the National Institutes of Health, Dr. Schatten is the recipient of an NIH MERIT, and earlier a Research Career Development, Award, was honored by the Czech Academy of Sciences with their Purkinje Medal of Science, elected as a Fellow and later a Delegate of the American Association for the Advancement of Sciences, a Mentor Awardee of the American Society for Cell Biology, Elected Australian Society for Reproductive Biology President’s Lecturer, awarded the Daniel Mazia Award from Stanford University and a Doctor Honoris Causa (Honorary Doctorate) from the University of Nova Gorica, presented by the President of the Republic of Slovenia, among other honors. He is the 2019 Johan Gregor Mendel Lecture Awardee speaking at Mendel’s home, the Augustinian Abbey in Brno, Czech Republic. His > 300 papers on stem cells, regeneration, fertilization, cell biology, development, infertility, assisted reproductive technologies, as well as strategies for rectifying past injustices in scientific careers, have appeared in premier journals including Nature and Science. Dr. Schatten is also an eloquent advocate for research in reproduction, development, regeneration and stem cells.
Varykina Thackray, Ph.D. is a Professor of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Diego. Dr. Thackray is interested in understanding how cross-talk between the gut microbiome and the host influences the pathology of polycystic ovary syndrome (PCOS), a disorder that affects 10% of women worldwide. In addition to infertility and pregnancy complications, many women with PCOS have metabolic dysregulation that results in an increased risk of developing obesity, type 2 diabetes, hypertension, and non-alcoholic fatty liver disease. Dr. Thackray’s research showed that changes in the gut microbiome are associated with PCOS and hyperandrogenism, both in women and in a PCOS mouse model. Moreover, these studies demonstrated that exposure to a healthy microbiome improved metabolic and reproductive symptoms in a PCOS mouse model. These studies suggest that androgens may influence the gut microbiome in females and that modulation of this microbial community may be a potential therapy for PCOS.
Position/Occupation: Associate consultant and Physician scientist in Reproductive Endocrinology and Infertility
University/Hospital/Association: Center of Assisted Reproduction and Embryology, the University of Hong Kong Shenzhen Hospital, Shenzhen, China
Biography: Dr. Tianren Wang received her M.D. degree at the China Meidcal University in 2009 and Ph.D degree at Peking University (Beijing China) in 2014. She completed her postdoctoral training at Yale School of Medicine in 2017. Dr. Wang was the recipient of the In-Training Research Award (2016) from Americian Society of Reproduction Meidicne and President’s Presenter Award(2017) from Society for Reproductive Investigation. Her clinical and research interest are female fertility preservation, mitpchondria and ovarian aging and embryo development. Dr. Wang is currently sharing her clinical work with research and she is conducting clinical and translational research projects, supported by the National Natural Science and Foundation of China. She has published more than 20 peer-reviewed papers in Nature Communications, Cell Stem Cell, Aging cells, Human Reproduction and other prestigious journals.
📢Save the date for The 8th World Congress on Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis (CoGEN)
Saturday November 6, 2021
10:30-15:30 Central European Time (CET)
Registration is FREE:https://cogenlive.cme-congresses.com/registration/
We invite you to submit your abstract!
Abstract Submission Deadline: September 10, 2021
Accepted abstracts will be presented in PDF format at the 4th IVF Worldwide Online Congress October 1-3, 2021:
REGISTER FREE here:https://ivflive.cme-congresses.com/registration-4th/
We are proud to invite you to the 2nd Online Congress on Future Innovations for Embryologists!
Friday - Saturday, June 4-5, 2021
Starting 9am EDT (NY), 3pm Paris, 9pm HK
Click HERE to register for FREE today:
Final countdown has officially started! IVF Worldwide Online Congress will start in just 12 DAYS!
Register yourself today, it's FREE: https://lnkd.in/dYSVYDt
View the Full scientific program & get familiar with our top faculty here: https://lnkd.in/dQ3BYap
We are excited to invite you to take a look at the outstanding preliminary program of the upcoming 3rd IVF Worldwide Online Congress:
Optimizing IVF treatment to maximize the likelihood of conception
Registration is OPEN & FREE: https://lnkd.in/dYSVYDt
This site place cookies on your machine for reasons including keeping track of your preferences, collecting aggregated statistics to analyze how our site is used, and to show you ads tailored to your interests. ACCEPT
Privacy, Cookies Policy, General Terms and Conditions of Use
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.